rgls8429
·Code: RGLS8429
rgls8429: developed by 1 company · 1 clinical trial tracked. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| Regulus Therapeutics Inc. (RGLS) | Phase 1 |
Clinical Trials (1)
A Phase 1, Double-Blind, Placebo-Controlled, Single Ascending Dose Study in Healthy Volunteers to Evaluate the Safety, Tolerability, and Pharmacokinetics of RGLS8429
Frequently asked questions
Who is developing rgls8429?
rgls8429 is being developed by Regulus Therapeutics Inc..
How many clinical trials involve rgls8429?
BioSniper tracks 1 clinical trial involving rgls8429.
Get deeper analysis on rgls8429
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis